Sundaram Mutual Fund increased its stake in Indegene Limited from 1.70% to 1.90% by acquiring an additional 485,255 shares. This increased its total holdings to 4,580,721 shares. The value of the acquired shares was approximately ₹26.46 crore, based on a share price of ₹545.25.
A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.
Chennai-based AMC founded in 1996 as a joint venture with BNP Paribas, now wholly owned by the Sundaram Finance Group. Manages over Rs 1 lakh crore. Strong brand in South India with equity funds that have delivered consistent long-term track records across market cycles. Sundaram Mid Cap Fund has been a flagship since the early 2000s.
